Septodont
Septodont
Septodont
     This 18th issue features one RTR case and three Biodentine™
     cases:
        RTR Bone grafting aims at preserving bone dimensions
        
        especially when tooth removal is discussed. It is fully
        resorbable & osteoconductive. Its remarkable properties
        promotes formation of patient’s new bone & paves the way for
        future successful treatment plans.
       Biodentine™, the first biocompatible and bioactive dentin
        replacement material. Biodentine™ uniqueness not only lies
        in its innovative bioactive and “pulp-protective” chemistry, but
        also in its universal application, both in the crown and in the
        root.
                             Content
Alveolar ridge preservation with RTR
Dr Bozidar Brkovic
                                        04
                                             3
    Preservation of alveolar ridge
    in the maxillary esthetic
    zone using R.T.R. Cone and
    Hémocollagène
    Author: Prof. Božidar Brkovic DDS, MSc, PhD
    Professor of Oral Surgery, Implant Dentistry and Dental Anaesthesia, School
    of Dental Medicine, University of Belgrade, Serbia.
      Introduction
    Timing of placement implant in the esthetic zone          using bone substitutes (Buser et al. 2007, Chen,
    is closely related to the reduction of risk of esthetic   Buser 2008).
    complications and obtaining the primary implant           Beta tricalcium-phosphate (betaTCP) has a
    stability in the 3D implant position. Following           composition and structure very close to natural
    tooth extraction implant can be placed imme-              bone which ensure osteoconductive and
    diately, then early, with soft tissue healing and         biodegradable effect. BetaTCP can promote
    partial bone consideration, or after completed            osteoblast differentiation and proliferation which
    bone healing and remodeling of alveolar ridge.            is increase in a combination with the type  I
    Although the late implant placement can obtain            collagen because of a biocompatibility with
    initial stability of implants and adequate structure      variety of human cells and proteins in a process
    and quality of residual bone, early implant               of bone healing (Ormianer et al. 2006, Yang et
    placement is determined with increased level of           al. 2013). The bioactivity of betaTCP and type I
    cellular osteogenic activities inside the socket          collagen (R.T.R. Cone, Septodont, France) has
    walls with a soft tissue healing that can provide         been confirmed in previous clinical, in vitro and in
    the adequate volume and counter of soft tissue            vivo studies (Brkovic et al. 2008, 2012, Schwartz
    with enough keratinized gingiva of esthetic zone.         et al. 2007, Zou et al. 2005).
    On the other hand, timing of immediate implant            Preservation al alveolar ridge immediately after
    placement is followed with strict indications             tooth extraction may provide reliable support
    depending of alveolar socket morphology and               to maintain the initial volume and morphology
    possibility of resulting in primary implant stability.    of bone and soft tissue in the esthetic zone
    However, all of timing protocols for implant place-       (Vignoletti et al. 2012). This procedure is a less
    ments are characterized by a greater or lesser            invasive procedure of augmentation of alveolar
    extent of slight flattening to significant resorption     ridge which change a structural architecture
    of socket walls requiring contour augmentation            of the regenerate bone inside the socket and
4
to minimize the absorption of external tissue.                            used for the preservation of alveolar ridge imme-
Therefore, the preservation of alveolar ridge                             diately after tooth extraction and for stabilization
volume is essential to achieving a successful                             of the alveolar soft tissue with collagen sponge
and esthetically-driven implant prosthodontic                             of bovine origin at the same preservation sites,
rehabilitation in esthetic zone.                                          the aim of this report was to point out surgical
Since there is no data showing the effect of a                            steps, characteristic of method and positive
composition of betaTCP and type I collagen                                results of bone and soft tissue regeneration.
(betaTCP/Clg) in the maxillary esthetic zone
Fig. 1: Periodontal disease - indication for extraction Fig. 2: Postextraction sockets with socket wall deficience
Fig. 3: R.T.R. Cone insertion for preservation of alveolar ridge in the   Fig. 4: R.T.R. Cone inside the socket walls
maxillary esthetic zone
                                                                                                                                       5
                                                                             reduction of crestal bone the filled sockets were
                                                                             covered with sponge collagen (Hémocollagène,
                                                                             Septodont, France) prepared for this indication.
                                                                             The collagen block was separated in two pieces
                                                                             with a sterile scissor and then modified by finger
                                                                             pressure to the form of one-layer membrane.
                                                                             One side of Hémocollagène membrane was
                                                                             positioned under the buccal while other side
                                                                             under the palatal attached gingiva which were
    Fig. 5: Preparation of R.T.R. Cone and Hémocollagène                     previously elevated for surgical exploration of
                                                                             sockets. Material and gingiva were secured
                                                                             with interrupted sutures for 7 days leaving the
                                                                             central part which corresponds with socket
                                                                             opening, to healing spontaneously (Fig. 6).
                                                                             The process of epithelization of the external
                                                                             surface of Hémocollagène membrane was
                                                                             taken approximately 20 days of healing what
                                                                             was accepted tie for clinical intraoral socket
                                                                             healing. During that period no side effects
                                                                             were recorded. After 4 months of regeneration,
                                                                             the preserved site was open and explored for
                                                                             implant insertion (AstraTech TX Implant System)
    Fig. 6: R.T.R. Cone and Hémocollagène secured with sutures
                                                                             (Fig. 7-11).
    Fig. 7: Preservation of alveolar ridge after 4 months                    Fig. 8: Preserved surgical site before implant placement, 4 months
                                                                             of healing
    Fig. 9: CBCT view of            Fig. 10: Implants AstraTech TX placement in the preservated sockets          Fig. 11: Radiography of
    4 months haling                                                                                              inserted implants
6
  Discussion
The placement of implants in the anterior           during the healing period of 9 months (Brkovic
maxilla has been a major challenge to surgeon       et al. 2012). The chemical composition of
due to insufficient bone volume in the maxillary    betaTCP has an influence in the enhancement
esthetic zone as a result of expected physiolo-     of mineralization due to a local increase in
gical bone remodeling.                              a concentration of Na and phosphate ions
Different studies have shown that the anterior      directly stimulated osteoblast activity (Zerbo et
maxillary sites after tooth extraction have a       al 2005). Similar histomorphometric results of
high risk for bone remodeling and consequent        new bone formation were reported by Szabo et
reduction due to thin and vulnerable buccal         al. (2005) using betaTCP in patients undergoing
bone walls (Morjaria et al. 2014). It has been      sinus floor augmentation in period of 6 months
demonstrated that the most sites in the esthetic    of healing. In the same surgical model of sinus
zone have a less than 1 mm of buccal bone wall      lift procedure, Perieira et al. (2017) recently
thickness, while almost 50% of sites have a         reported similar amount of new bone formation
thickens less than 0.5 mm (Januario et al. 2011).   after betaTCP alone or in combination with
Furthermore, sites in the esthetic zone undergo     autogenous bone (approximately 45%) with
significant vertical reduction within 8 weeks of    positive immunostaining of bone samples
healing with a thickness of buccal bone wall        demonstrated high cellular activity for both
less of 1 mm, as shown in the CBCT analysis         materials. Regarding the stability of grafted
(Chappuis et al. 2013). Another interesting         area, de O. Gorla et al (2015) have shown that
outcome is documented in the retrospective          betaTCP alone or in combination with auto-
study of Lee and Poon (2016) reported that a        genous bone presented satisfactory results
secondary augmentation in the esthetic zone         for maxillary sinus lifting procedure regarding
was less after preservation of alveolar ridge,      the maintenance of graft volume during the
than after spontaneous post-extraction socket       healing phase before the insertion of implants,
healing. These facts are of special concern         as assessed by means of CBCT.
especially when tooth extractions are related       One of the important results which have to be
with periodontal disease where is objectively       underlined is the effects of collagen not only as
expected to have initial reduction of residual      a composite of betaTCP in R.T.R. Cone but also
bone in both width and height. Most usually         as a material for socket healing stabilization
that condition is treated prior to horizontal and   in a form of Hémocollagène sponge. Namely,
vertical augmentation including the principle       the use of type I collagen, clinically may cover
of guided bone regeneration than with preser-       and, in direct contact with blood clot, bond the
vation method.                                      socket opening what will secure particles of
The use of betaTCP with collagen type I for         material during early phase of healing. From the
preservation of alveolar ridge is now a standard    standpoint of biology, addition usage of type I
method with promising results. It has been          collagen may decrease time for collagen deve-
shown that healing of post-extraction sockets       lopment, stimulate precursor cells, increase
resulted in approximately 42% of new bone           osteoblast activity and increase of quality of
and marrow bone with 10% of residual graft,         regeneration (Zou et al 2005).
                                                                                                        7
                      Authors:
    References
    1. Brkovic B, Prasad, H, Rohrer M, Konandreas G, Agrogianis G, Antunovic D, Sandor G. Beta-tricalcium
        phosphate/type I collagen cones with or without a barrier membrane in human extraction socket
        healing: clinical, histologic, histomorphometric, and immunohistochemical evaluation. Clin Oral Invest
        2012;16:581-590.
    2. Brkovic B, Prasad, H, , Konandreas G, Radulovic M, Antunovic D, Sandor G, Rohrer M. Simple
        preservation of a maxillary extraction socket using beta-tricalcium phosphate with type I collagen:
        preliminary clinical and histomorphometric observation. JCDA 2008;16:581-590.
    3. Buser D, Belser U, Wismeier D. Implant therapy in the esthetic zone – single tooth replacement. Berlin,
        London. Quintessence, 2007.
    4. Chappuis V, Engel O,Reyes M, Shahim K, Nolte LP, Buser D. Ridge alterations post-extraction in the
        esthetic zone: a 3D analysis with CBCT. J Dent Res 2013;92:195S-201S.
    5. Chen S, Buser D. Implant placement in the post-extraction sites – treatment options. Berlin, London.
        Quintessence, 2008.
    6. Januario AL, Duarte WR, Barriviera M. Dimension of the facial bone wall in the anterior maxilla: a cone-
        beam computed tomography study. Clin Oral Impl Res 2011;22:1168-71.
    7. Lee AMH, Poon CY. The clinical effectivness of alveolar ridge preservation in the maxillary anterior
        esthetic zone - a retrospective study. J Esthetic Restorative Dent 2017;29:137-145.
    8. Morjaria K, Wilson R, Palmer R. Bone healing after tooth extraction with or without an intervention: a
        systemic review of randomized controlled trials. Clin Implant Dent Related Res 2014;16:1-20.
    9. Ormianer Z, Palti A, Shifman A. Survival of immediately loaded dental implants in deficient alveolar bone
        sites augmented with beta-tricalcium phosphate. Implant Dent 2006;15:396-401.
8
10. Schwarz F, Herten M, Ferrari D, Wieland M, Schmitz L, Engelhardt E, Becker J. Guided bone
     regeneration at dehiscence-type defects using biphasic hydroxyapatite + beta tricalcium phosphate
     (Bone Ceramic) or a collagen-coated natural bone mineral (BioOss Collagen): an immunohistochemical
     study in dogs. Int J Oral Maxillofac Surg 2007;36:1198-206.
11. Szabo G, Huys L, Coulthard P, Maiorana C, Garagiola U, Barabas J et al. A prospective multicentar
     randomized clinical trial of autogenous bone versus beta-tricalcium phosphate graft alone for
     bilateral sinus elevation: histologic and histomorphometric evaluation. Int J oral Maxillofac Implants
     2005;20:37-381.
12. Zerbo IR, Bronckers AL, de Lange G, Burger E. Localization of osteogenic cells and osteoplastic cells in
     porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomatrials
     2005;26:1445-1451.
13. Zou C, Weng W, Deng X, Cheng K, Liu X, Du P et al. Preparation of characterization of porous beta-
     tricalcium phosphate/collagen composites with an integrated structure. Biomaterials 2005;26:5276-
     5284.
14. Vignoletti F, Matesanz P, Rodrigo D, Figuero E, Martin C, Sanz M. Surgical protocols for ridge
     preservation after tooth extraction. A systematic review. Clin Oral Implants Res 2012;23 Suppl 5:22-38.
15. Yang C, Unursaikhan O, Lee J, Jung U, Kim C, Choi S. Osteoconductivity and biodegradation of
     synthetic bone substitutes with different tricalcium phosphate contents in rabbits. J Biomed Mat Res
     2013;6:1-9.
  R.T.R.
        A complete solution
             for your bone needs
      Biodentine™ as direct pulp
      capping material in teeth with
      mature apices.
      Authors: Jenner Argueta D.D.S. M.Sc. -- Melisa Valenzuela, Br.
       Introduction
     Awareness of the importance of preserving            nociceptive functions, and the defense system
     the vitality of the pulpo-dentinal complex has       of the body itself. Thanks to the abovemen-
     resulted in conservative management of pulpal        tioned items, among others, it has been shown
     pathologies becoming more and more popular           that longer survival time is achieved in teeth
     over time; this is due in part to current advances   without root canal treatment when compared
     in regard to protocols and appropriate mate-         with endodontically treated teeth (1, 3-5).
     rials for vital pulp therapy procedures, and
     the economic factors that influence deci-            Included amongst the materials used to
     sion-making in many countries and lead many          perform pulp therapy procedures are bioce-
     patients to opt for premature tooth extraction       ramic cements; these biocompatible mate-
     because of the costs involved in root canal          rials are divided into three basic groups: 1.
     treatment and subsequent restoration (1, 2).         High strength bio-inert cements; 2. Bioactive
                                                          cements, which form chemical bonds with
     Pulp tissue may become exposed to the oral           mineralized tissue; and 3. Biodegradable
     environment, whether due to dental caries,           materials that participate actively in the body's
     or mechanically as a result of restorative or        metabolic processes (6). Multiple bioceramic
     prosthetic procedures. One treatment option          materials are currently available on the market;
     for pulp exposure is the application of conser-      the most well known of these materials are
     vative vital pulp therapy procedures, which          MTA and Biodentine™, both of which belong to
     may include direct pulp capping, indirect pulp       the bioactive cements group. Biodentine™ is a
     capping if the tissue is not fully exposed, and      dentin substitute and dentinogenesis promoter
     partial or total pulpotomy; this permits the         with the following properties: alkaline pH,
     preservation of the vitality of the tooth, its       biocompatibility, antibacterial action, release
10
of calcium and hydroxyl ions, radiodensity
similar to dentin, setting time of approximately
12 minutes, insolubility, outstanding sealing
properties, and causes no tooth discolo-
ration (7-11); this last property makes it the
material of choice when treatments need to be
performed involving the coronal and cervical
areas whether of anterior or posterior teeth.
  Clinical case
Patient, 22 years of age, visits the dental clinic   this step did not need to be performed, so the
presenting short-duration elicited pain in tooth     cavity was disinfected with sodium hypochlorite
no. 19 (Fig. 3 and 4); having established a          2.5%, and Biodentine™ was placed to serve
diagnosis of reversible pulpitis, we proceeded       as a direct pulp-capping material (Fig. 7) using
to caries removal under absolute isolation           the "MAP System" dental materials micro-ap-
(Fig.  5) producing a slight pulpal exposure         plicator. Approximately 75% of the cavity was
with no hemorrhaging; this type of exposure          filled with Biodentine™ (Fig. 8); Cavit-G was
may go unnoticed if a correct assessment of          then placed over this to serve as a provisional
the preparation floor is not performed with          restorative material, and seven days after
an endodontic explorer (Fig. 6). In the cases        the procedure the patient was evaluated to
where hemorrhage did occur, it was stopped           confirm that he was completely asymptomatic
by the application of sustained pressure for 10      and that the tooth was responding normally to
seconds with a cotton swab moistened with            sensitivity tests so that we could proceed to
sterile saline solution; in this particular case     final restoration (Fig. 9 and 10).
                                                                                                        11
     Fig. 3                            Fig. 4                           Fig. 5
Fig. 9 Fig. 10
        Follow-up
     All patients were re-evaluated at 3, 6 and 12     the sensitivity tests was normal; all teeth went
     months after their pulp-capping appointment.      on to final restoration in acceptable conditions,
     In clinical situations such as this, we hope to   and in 14 of the 20 cases (70%) it was possible
     see radiographic evidence of mineralized tissue   to clearly observe radiographic evidence of
     formation under the cap between six and nine      mineralized tissue formation under the pulp
     months post-procedure (12).                       capping material; a supplementary examination
     All 20 cases were re-examined at 12 months        is planned at 24 months post-procedure for all
     of follow-up, and in all cases the response to    these cases.
12
  Discussion
From an entirely optimistic perspective, the         these types of situations vital pulp therapy may
ultimate goal of any dentist when performing         achieve a successful outcome (1, 18-20).
restorative and/or endodontic procedures             In regard to the long-term success of conser-
should be the maintenance of the pulp vitality       vative pulp procedures, it is extremely
and functionality of the tooth, with no discomfort   important that the tooth be provided with a
for the patient (13).                                definitive final restoration that guarantees an
Obtaining an adequate diagnosis is key to the        adequate marginal seal, since this last factor,
success of conservative pulpal therapy; an           in conjunction with the absence of bacterial
ideal case is one where we have a diagnosis          contamination during the procedure, is among
of reversible pulpitis with no history of spon-      the most important factors to be taken into
taneous or long-lasting dental pain(14), as it       consideration in view of preventing subse-
is generally accepted that a history of spon-        quent pulp inflammation (21, 22). The reported
taneous or nocturnal pain is associated with the     success rate for vital pulp therapy procedures
presence of an irreversible pulp inflammation        using bioactive cements is greater than 80% in
process(15, 16). In these cases, the success of      examinations at up to 10 years (23); this is a
direct pulp capping may be questionable (17),        very high percentage for a dental procedure in
although some studies have shown that even in        such operational time frames.
  Conclusion
Based on the clinical results obtained in the        with Biodentine™ teeth presenting reversible
present series of cases and taking into consi-       pulpitis is highly effective for the maintenance
deration the limitations inherent in the study,      of pulp vitality.
we can conclude that direct pulp capping
Authors:
                Melisa Valenzuela, Br
                Dentistry Student
                Mariano Gálvez University of Guatemala
                                                                                                        13
     References
      1. Asgary S, Eghbal MJ, Fazlyab M, Baghban AA, Ghoddusi J. Five-year results of vital pulp therapy in
          permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial. Clin
          Oral Investig 2015;19(2):335-341.
      2. Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis
          using biomaterials: a multi-center randomized controlled trial. Acta Odontol Scand 2013;71(1):130-136.
      3. Aguilar P, Linsuwuanont P. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: A
          systematic review. Journal of Endodontics 2012;37(5).
      4. Asgary S, Eghbal MJ, Ghoddusi J, Yazdani S. One-year results of vital pulp therapy in permanent molars
          with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial. Clin Oral
          Investig 2013;17(2):431-439.
      5. McDougal RA, Delano EO, Caplan D, Sigurdsson A, Trope M. Success of an alternative for
          interim management of irreversible pulpitis. Journal of the American Dental Association (1939)
          2004;135(12):1707-1712.
      6. Koch K, Brave D. EndoSequence: melding endodontics with restorative dentistry, part 3. Dentistry today
          2009;28(3).
      7. Bakhtiar H, Hossein M, Aminishakib P, Abedi F. Human Pulp Responses to Partial Pulpotomy Treatment
          with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial. Journal of Endodontics
          2017;Article In Press.
      8. Malkondu O, Karapinar Kazandag M, Kazazoglu E. A review on biodentine, a contemporary dentine
          replacement and repair material. Biomed Res Int 2014;2014:160951.
      9. Miller AA, Takimoto K, Wealleans J, Diogenes A. Effect of 3 Bioceramic Materials on Stem Cells of the
          Apical Papilla Proliferation and Differentiation Using a Dentin Disk Model. J Endod 2018.
     10. Nowicka A, Lipski M, Parafiniuk M. response of human dental pulp capped with biodentine and mineral
          trioxide aggregate. Journal of Endodontics 2013;39(6).
     11. Villat C, Grosgogeat B, Seux D, Farge P. Conservative approach of a symptomatic carious immature
          permanent tooth using a tricalcium silicate cement (Biodentine): a case report. Restor Dent Endod
          2013;38(4):258-262.
     12. Maroto M, Barberia E, Planells P, Garcia Godoy F. Dentin bridge formation after mineral trioxide
          aggregate (MTA) pulpotomies in primary teeth. American journal of dentistry 2005;18(3):151-154.
     13. Zanini M, Meyer E, Simon S. Pulp Inflammation Diagnosis from Clinical to Inflammatory Mediators: A
          systematic review. J Endod 2017.
     14. Camp J. Diagnosis dilemmas in vital pulp therapy: treatment for the toothache is changing, especially in
          young, immature teeth. Journal of Endodontics 2008;34(7S):S6.
     15. Endodontics aAo. Endodontic Diagnosis Colleagues for Excellence 2013(Fall 2013).
     16. Mejare IA, Axelsson S, Davidson T, Frisk F, Hakeberg M, Kvist T, et al. Diagnosis of the condition of the
          dental pulp: a systematic review. International endodontic journal 2012;45(7):597-613.
     17. Barrieshi-Nusair KM, Qudeimat MA. A prospective clinical study of mineral trioxide aggregate for partial
          pulpotomy in cariously exposed permanent teeth. J Endod 2006;32(8):731-735.
     18. Matsuo T, Nakanishi T, Shimizu H, Ebisu S. A clinical study of direct pulp capping applied to carious-
          exposed pulps. J Endod 1996;22(10):551-556.
     19. Mejare I, Cvek M. Partial pulpotomy in young permanent teeth with deep carious lesions. Endodontics &
          dental traumatology 1993;9(6):238-242.
     20. Caliskan MK. Pulpotomy of carious vital teeth with periapical involvement. International endodontic
          journal 1995;28(3):172-176.
     21. Swift EJ, Trope M, Ritter AV. Vital pulp therapy for the mature tooth – can it work? Endodontic Topics
          2003(5).
     22. Rechenberg DK, Zehnder M. Molecular diagnostics in endodontics. Endodontic Topics 2014;30(1):51-65.
     23. Johannes Mente et al. Treatment outcome of mineral trioxide aggregate or calcium hydroxide direct pulp
          capping: long-term results. Journal of endodontics 2014;40(11).
14
Direct pulp capping in immature
permanent teeth
Authors: Dr. Gloria Saavedra-Marbán, Dr. Eugenio C. Grano de Oro-Cordero,
Dr. Cristina González Aranda
  Introduction
Direct pulp capping (DPC) is a procedure that          present and ensuring the lesion is properly
is usually performed on children or young              sealed using a material that is well-tolerated by
persons with permanent teeth that have open            the dental pulp.
apices and are showing dental lesions close to         Throughout history, different materials and tech-
the pulp tissue. This loss of dental structure can     niques have been used for direct pulp capping
be caused by deep caries, trauma or minerali-          in immature permanent teeth.
zation defects in the tooth structure.                 Traditionally, calcium hydroxide has been
In these cases, the patient may notice some            used as a material for pulp capping, due to
degree of discomfort to stimuli (primarily the         its effective antibacterial properties. However,
cold or sugary foods), although not showing any        there are some long-term disadvantages due
signs of spontaneous sensitivity. X-rays usually       to its high solubility and inability to adhere to
show lesions close to the pulp without indica-         dentin. Subsequently, etching techniques have
tions of pulpal degeneration, so there is likely       been used on the pulp for dentin bonding and
to be pulpal exposure if the decayed tissue is         sealing it with a permanent filling material, but
completely removed during the operation.               several studies have shown poor biocompa-
The purpose of direct pulp capping is to               tibility of these resin-based materials with the
stimulate reparative dentin formation which            pulp. (1,2)
maintains the vitality of the pulp and, as a result,   The arrival of new bioactive materials has led
allowing the apex to continue developing. This         to an increased success in direct pulp capping.
is achieved by removing any microorganisms             Among them, MTA® and Biodentine™ are well-
                                                                                                           15
     known options. MTA has been used since 2000          setting time (12 minutes), and it does not cause
     due to its biocompatibility with the pulp and its    dental discoloration because it does not contain
     insolubility, with numerous studies showing          bismuth oxide. (4-6)
     higher percentages of long-term success when         Currently, there are numerous clinical studies
     using this material than when calcium hydroxide      on the effectiveness of Biodentine as a direct
     was used. (3)                                        pulp-capping material. (7-11)
     Biodentine™ was introduced in 2010 and has           In our clinical practice, the direct pulp capping
     very similar physical and biological properties      procedure consisted of caries removal up to
     to dentin, as it is a biocompatible and bioactive    the pulpal chamber, filling in the cavity with
     material that induces pulp repair. It has simpler    Biodentine™ and sealing it with, in our case, a
     handling properties to MTA, such as a shorter        composite resin.
16
Fig. 4: Appearance after the application of     Fig. 5: 37% orthophosphoric acid applied        Fig. 6: Cavity filled with a hybrid resin
Biodentine™.                                    to the enamel.                                  composite.
Fig. 9: X-ray at 18-month follow-up appointment showing dentin         Fig. 10: X-ray at 30-month follow-up appointment showing the
bridge formation underneath the Biodentine™, as well as apical         positive progression of the treatment.
closure.
   Conclusion
In this clinical case study, the clinical and radiographic findings reveal that Biodentine™ exhibits good
clinical and radiographic behavior in direct pulp capping treatment in immature permanent teeth.
                                                                                                                                                17
     References
      1. Gwinnett AJ, Tay FR. Early and intermediate time response of the dental pulp to an acid etch technique
          in vivo. Am J Dent 1998;11:534-45
      2. Rodrigues ML, Loguercio AD, Reis A, Muench, Cavalcanti de Araujo V. Adverse effects of human pulps
          after direct pulp capping with the different components from a total-etch, three-step adhesive system.
          Dent Mater 2005;21:599–607
      3. Zhaofei L, Lihua C, Mingwen F, Qingan X. Direct Pulp Capping with Calcium Hydroxide or Mineral
          Trioxide Aggregate: A Meta-analysis. J Endod 2015;41:1412–7.
      4. Cuadros C. Estudio clínico comparativo de diferentes agentes pulpares en pulpotomías de molares
          primarios. [Comparative clinical study of different pulp agents for pulpotomy of primary molars]
          Doctorate thesis. Barcelona: International University of Catalonia. 2013.
      5. Niranjani K, Prasad MG, Vasa AA, Divya G, Thakur MS, Saujanya K. Clinical evaluation of success of
          primary teeth pulpotomy using Mineral Trioxide Aggregate®, Laser and Biodentine TM an In Vivo Study.
          J Clin Diagn Res 2015; 9(4): 35-7.
      6. Biodentine™. Active Biosilicate Technology™. Scientific File. Septodont Brochure.
      7. Linu S, Lekshmi MS, Varunkumar VS and Sam Joseph VG: Treatment Outcome Following Direct
          Pulp Capping Using Bioceramic Materials in Mature Permanent Teeth with Carious Exposure: A Pilot
          Retrospective Study. J Endod 2017;43:1635–9.
      8. Awawdeh L, Al-Qudah A, Hamouri H and Chakra RJ: Outcomes of Vital Pulp Therapy Using Mineral
          Trioxide Aggregate or Biodentine: A Prospective Randomized Clinical Trial. J Endod 2018;44:1603–9.
      9. Parinyaprom N, Nirunsittirat A, Chuveera P, Lampang SN, Srisuwan T, Sastraruji T, Bua-on P, Simprasert
          S, Khoipanich I, Sutharaphan T, Theppimarn, S, Ue-srichai N, Tangtrakooljaroen W and Chompu-inwai
          P: Outcomes of Direct Pulp Capping by Using Either ProRoot Mineral Trioxide Aggregate or Biodentine
          in Permanent Teeth with Carious Pulp Exposure in 6 to 18 Year-Old Patients: A Randomized Controlled
          Trial. J Endod 2018;44:341–8.
     10. Bakhtiar H, Nekoofar MH, Aminishakib P, Abedi F, Moosavi FN, Esnaashari E, Azizi A, Esmailian S,
          Ellini MR, Mesgarzadeh V, Sezavar M, and About I: Human Pulp Responses to Partial Pulpotomy
          Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial. J Endod
          2017;43:1786–91.
     11. Brizuela C, Ormeño A, Cabrera C, Cabezas R, Inostroza C, Ramírez V and Mercadé M: Direct Pulp
          Capping with Calcium Hydroxide, Mineral Trioxide Aggregate, and Biodentine in Permanent Young Teeth
          with Caries: A Randomized Clinical Trial. J Endod 2017;43:1776–80.
18
Pulpotomy in primary teeth
using Biodentine™: 18-month
follow-up
Dr. Gloria Saavedra Marbán, Dr. Cristina González Aranda
  Introduction
The pulpotomy treatment is performed on the          innocuous to the pulp and surrounding tissues,
primary tooth with deep caries or traumatic          as well as possess the ability to stimulate the
lesions, provided that it only affects the pulp in   healing of the radicular pulp without interfering
the pulpal chamber. In these cases, the radicular    with the physiological process of resorption,
pulp is able to form tertiary dentin as a repa-      keeping the radicular pulp alive and healthy (4,5).
rative response from the dentin-pulp complex.        The pulpotomy procedure is frequently catego-
The purpose of this procedure is to preserve the     rized according to different treatment objectives:
vitality and function of the remaining radicular     devitalization (mummification, cauterization),
pulp until the primary tooth’s physiological exfo-   preservation (minimal devitalization) or regene-
liation. (1, 2).                                     ration (repair) (6).
The degree of damage to the primary tooth must       Devitalization refers to the destruction of vital
be taken into account, because the pulpotomy         tissue, an effect achieved using formocresol,
treatment could fail if it is not possible to        which, for decades, was considered the
adequately reconstruct the tooth and seal the        material of choice in pulpotomies in primary
crown. (3,4).                                        teeth. However, its cytotoxicity and its potential
Throughout history, different materials have been    mutagenicity and carcinogenicity caused it to fall
used to perform pulpotomies in primary teeth         into disuse.
with different mechanisms of action in many          Preservation is achieved using materials that try
cases. These materials had to meet the following     to maintain the vital pulp, but without inducing
requirements: present a bactericidal effect, be      the formation of reparative dentin. This can be
                                                                                                           19
     achieved with ferric sulphate or glutaraldehyde.                 rials with its shorter setting time. Additionally, its
     Lastly, there is regeneration which is when the                  radiodensity is due to the fact that it contains
     material used is able to maintain the vital pulp                 zirconium oxide rather than bismuth oxide, so it
     tissue as well as stimulate the formation of repa-               doesn’t discolor the tooth (11-13).
     rative dentin (7). The materials are made from                   The working time is about 6 minutes, with the
     calcium silicate, based on "Portland Cement";                    setting time being between 10 and 12 minutes
     MTA® being the most well-known product in this                   after mixing. This allows the pulpotomy treatment
     category. Pulpotomy studies with this material                   and reconstruction to be carried out during the
     have reported very positive results (8-10).                      same clinical appointment, which is very advan-
     Recent studies show that Biodentine™ has very                    tageous when treating the child patient (13).
     similar physical and biological properties to                    Below we present two clinical cases. In the first
     dentin, as it is a biocompatible and bioactive                   clinical case, we will provide a systematic review
     material that induces pulp repair. It has simpler                of the pulpotomy procedure using Biodentine™.
     handling properties than other bioactive mate-
     Fig. 1: Clinical view of molar 8.5.   Fig. 2: Initial right bitewing X-ray.         Fig. 3: Complete isolation of the fourth
                                                                                         quadrant using a rubber dam.
20
Fig. 4: Once the caries lesion was            Fig. 5: Appearance of the opening to the       Fig. 6: Image after Biodentine™ has been
removed, the pulp chamber was dried with      root canals once it has clotted.               applied.
a cotton ball, the crown was then cut and
adjusted, and the dental pulp was removed.
Fig. 7: Clinical view of the molar with the   Fig. 8: Right bitewing X-ray after 6 months.   Fig. 9: Right bitewing X-ray after
cemented crown, once the isolation was                                                       18 months.
removed.
5. The dental pulp is cut out using a slow-speed                      8. Biodentine™ is applied to the pulp stumps
    rotary instrument with a large round bur                               and is used to fill the cavity (Fig. 6).
    (Komet® 0.21mm round tungsten-carbide                              9. The preformed metal crown is adapted and
    bur), so that a clear and tear-free section of                         cemented in (3M™ ESPE™) with self-curing
    the pulp stumps remains at the opening to                              glass-ionomer cement (Ketac™ Cem Easy Mix).
    the radicular pulp.                                                10. The isolation device is removed, the bite is
6. The chamber is cleaned with water and dried                           checked, and the residual cement is cleaned
    with a piece of a cotton ball and checked to                          up (Fig. 7).
    ensure that no pulp remains in the chamber
    (Fig. 4).                                                          In the follow-up appointments scheduled 6
7. The pulp stumps are compressed using a                             and 18 months after the treatment, no clinical
    cotton ball to clot the wound. Gentle pressure                     or radiographic signs or symptoms were found
    should be applied, and the lesion should be                        (Figs. 8 and 9).
    visually checked for clotting (Fig. 5).
                                                                                                                                        21
        Clinical case report 2
     A 3-year-9-month-old patient visits our surgery                          crown  (Fig. 10). The clinical procedure was
     for the first time. The clinical examination                             carried out using a system similar to the one
     showed a deep caries lesion in molar 7.5. with                           previously described in Clinical Case Report 1
     clinical signs of reversible pulpitis. The periapical                    (Figs. 10, 11 and 12).
     X-ray confirms the proximity of the lesion to the                        Figs. 13, 14, 15 and 16 show the X-rays taken
     pulp without indicting any signs of lesion in the                        immediately after the treatment, as well as
     furcation or periapical areas, so the decision                           those taken at the 6-month and 18-month
     was to perform the pulpotomy treatment                                   follow-up appointments, which show dentin
     and reconstruct the tooth using a preformed                              bridge formation.
     Fig. 10: Initial periapical X-ray of tooth 7.5   Fig. 11: Appearance of the opening to the   Fig. 12: Biodentine™ applied to the pulp
     showing mesial-occlusal caries.                  root canals after clotting.                 chamber.
     Fig. 13: Clinical view of the molar with the     Fig. 14: Pulpotomy X-ray after Bioden-      Fig. 15: X-ray taken at the 6-month
     cemented crown, after the isolation system       tine™ treatment.                            follow-up appointment after Biodentine™
     was removed.                                                                                 pulpotomy treatment.
                                                         Conclusion
                                                      In this clinical case study, the clinical and radiographic findings
                                                      reveal that Biodentine™ exhibits good clinical and radiographic
                                                      behavior in pulpotomies in primary teeth. However, more
                                                      long-term randomized controlled clinical trials which support
     Fig. 16: X-ray taken at the 18-month
                                                      these observations would be desirable.
     follow-up appointment after Biodentine™
     pulpotomy treatment. Dentin bridge forma-
     tion can be seen in the mesial root.
22
                Author:
References
1. Weisshaar S. Endodoncia en las denticiones primaria y mixta. Indicaciones, materiales y procedimientos
    para el tratamiento pulpar. [Endodontics in primary and mixed dentitions. Indications, materials and
    procedures for pulp therapy.] Quintessence Int 2001;52:371-9.
2. Fucks AB. Vital pulp therapy with new materials for primary teeth: new directions and treatment
    perspectives. Pediatr Dent 2008;30:211-9.
3. Rodd HD, Waterhouse PJ, Fucks AB, Fayle SA, Moffatuk MA. Pulp therapy for primary molars. National
    Clinical Guidelines in Paediatric Dentistry. Int J Paediatr Dent 2006;16 (Suppl. 1):15–23.
4. Maroto-Edo M. Estudio clínico del agregado trióxido mineral en pulpotomías de molares temporales.
    [Clinical study of the mineral trioxide aggregate in pulpotomies in primary molars.] Doctorate Thesis.
    Madrid: Complutense University of Madrid. 2003.
5. Sonmez D, Sari S, Cetinbas T. A comparison of four pulpotomy techniques in primary molars: a long
    term follow up. J Endod 2008;34(8):950-5.
6. Ng FK, Messer B. Mineral trioxide aggregate as a pulpotomy medicament: An evidence-based
    assessment. Eur Arch Paediatr Dent 2008;9(2):58-73.
7. Cortés-Lillo O, Boj-Quesada JR. Tratamientos pulpares en la dentición temporal. [Pulp therapy
    in primary dentition.] En Boj JR, Catalá M, García-Ballesta C, Mendoza A, Planells P, editores.
    Odontopediatría. La evolución del niño al adulto joven. [Development from child to young adult.] Madrid:
    Ed. Ripano SA; 2011, p 337-350.
                                                                                                               23
      8. Simancas-Pallares MA, Díaz-Caballero AJ, Luna-Ricardo LM. Mineral trioxide aggregate in primary teeth
          pulpotomy. A systematic literature review. Med Oral Patol Oral Cir Bucal 2010;15(6):942-6.
      9. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide
          aggregate and formocresol for pulpotomy in primary molar teeth. Int Endod J 2007;40:261–267
     10. Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year
          follow-up. Int Endod J 2010;43:413–418.
     11. Cuadros C. Estudio clínico comparativo de diferentes agentes pulpares en pulpotomías de molares
          primarios. [Comparative clinical study of different pulp agents for pulpotomy of primary molars]
          Doctorate thesis. Barcelona: International University of Catalonia. 2013
     12. Niranjani K, Prasad MG, Vasa AA, Divya G, Thakur MS, Saujanya K. Clinical evaluation of success of
          primary teeth pulpotomy using Mineral Trioxide Aggregate®, Laser and Biodentine TM an In Vivo Study.
          J Clin Diagn Res 2015; 9(4): 35-7.
     13. Biodentine™. Active Biosilicate Technology™. Scientific File. Septodont Brochure.
www.septodont.com
24
                      Biodentine                                             ™
    “First ever
     Biological
     Bulk Fill”
              Pediatrics                        Restorative               Endodontics
Innovative by nature